Pacific Biosciences of California (also known as PacBio) is pioneering long-read sequencing technology, which uses longer DNA segments to map the whole genome. Long-read sequencing can uncover ...

The Option has an exercise price of $1.18 per share, which is equal to the closing price of PacBio common stock on March 31, ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product ...

Sequencing solutions provider Pacific Biosciences of California (PACB) announced on Thursday the appointment of Jim Gibson to the post of CFO, effective March 31.

Pacific Biosciences of California has hired Jim Gibson as its new chief financial officer, effective March 31.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable ...

Pacific Biosciences of California, Inc designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products ...

Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price objective lowered by analysts at Scotiabank from $6.00 to $2.00 in a research note issued on Tuesday,Benzinga reports.

A Closer Look Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $2.04, a high estimate of $2.50, and a low estimate of $1.50.